和铂医药孵化公司签署CRH疗法合作协议

财中社
26 Feb

2月26日,和铂医药-B(02142)发布公告,宣布其孵化的创新型生物技术公司HBMAlpha Therapeutics已与一名业务伙伴签订授权及合作协议,以推进治疗多种疾病的促皮质素释放激素(CRH)的新型疗法。根据该协议,业务伙伴获得在全球范围内(不包括大中华区)开发任何包含或含有HBM9013的医药产品的独家授权。HBM9013/HAT001是和铂医药开发的一项抗CRH抗体疗程,旨在治疗...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10